Liminatus Pharma, Inc
Financing
SEC filings to 2026-10-05 · every row opens its filingShares on issue
56.0M
on 2026-06-30, from 26.0M on 2025-06-30 10-Q ↗
a raise that quarter, at its price
Newest
None
No S-3 or F-3 shelf on file in the last 30 months.
None
No at-the-market programme on file in the last 30 months.
Warrants
1
Warrants of every class as tagged in the XBRL facts on 2025-06-30, exercise price $11.50. 10-Q ↗
Cash
under 0.1 quarters
$0 on 2025-03-31 ÷ $363K a quarter of operating cash used, the average of four quarters. 10-Q ↗
| Date | What | Shares | Price | Gross | Filing |
|---|---|---|---|---|---|
| 2026-02-17 | Public offering | 13,813,000 | $0.29 | $4.0M | 424B4 ↗ |
| 2025-05-06 | Private placement | not read | $10.00 | $15.0M | 8-K ↗ |
Also on file: a 1-for-50 reverse split, 2026-08-20 8-K ↗